查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2028120

乙肝表面抗原檢測市場規模、佔有率、成長及全球產業分析：按類型和應用分類，區域洞察及2026-2034年預測

HBsAg Testing Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 169 Pages | 商品交期: 2-3個工作天內

價格

乙肝表面抗原檢測市場的成長要素

全球乙肝表面抗原檢測市場預計在2025年達到14.4億美元，2026年成長至15.3億美元，到2034年達到24.4億美元，2026年至2034年的複合年成長率為6.07%。北美在2025年佔市場主導地位，市佔率為38.89%，這得益於其先進的診斷基礎設施和強力的篩檢措施。

乙肝表面抗原（HBsAg）可檢測透過檢測血液中的病毒抗原，在乙肝病毒感染的診斷中發揮至關重要的作用。全球乙肝負擔的日益加重，加上公眾意識的提高和篩檢計畫的擴展，正顯著推動市場需求的成長。

市場促進因素

乙型肝炎負擔加重

乙型肝炎流行率的上升是推動乙肝表面抗原（HBsAg）檢測需求成長的主要因素。全球健康統計顯示，數百萬人患有慢性B型肝炎，因此迫切需要早期診斷和後續觀察。醫療機構和發展中地區感染風險的增加進一步加劇了檢測需求。

政府措施和篩檢計劃

世界各國政府和衛生組織都在積極推廣B型肝炎篩檢。指引建議定期進行檢測，特別是針對孕婦和成年人，這促使每年的檢測數量增加。旨在2030年根除乙型肝炎的全球計畫進一步推動了市場成長。

市場趨勢

先進診斷技術的廣泛應用

市場對化學冷光免疫檢測和快速診斷測試等先進診斷技術的需求日益成長。這些技術因其靈敏度高、出結果快、效率高等優點，在檢查室和即時檢測環境中均受到青睞。

擴大即時檢測範圍

市場正轉向即時檢測（POC​​），即使在偏遠地區和醫療資源有限的環境中也能實現快速診斷。此外，與數位醫療的融合以及家用檢測解決方案的普及，正在提高檢測的可及性和便利性。

市場限制因素

準確度和誤差結果的局限性

由於靈敏度和環境條件的限制，B肝表面抗原（HBsAg）檢測可能出現假陽性或假陰性結果。這些誤差會影響診斷的可靠性，並阻礙其廣泛應用。

替代測試方法的存在

抗-HBs 檢測和 IgM 抗-HBc 檢測等替代診斷方法的存在可能會降低對 HBsAg 檢測的依賴，這可能會阻礙市場成長。

市場機遇

擴大研發規模，開發創新測試解決方案

市場相關人員和研究機構正大力投資開發先進的診斷工具，包括自我測試檢測套組和快速檢測方法。這些創新旨在提高早期檢測率，並擴大全球檢測的覆蓋範圍。

新興市場的擴張

在發展中地區，人們對疾病的認知不斷提高，醫療基礎設施不斷改善，政府加大了對抗疾病的力度，這些都為當地創造了巨大的發展機會。

細分分析

按類型

由於定性檢測在初步篩檢和診斷中的廣泛應用，預計到2026年，定性檢測將佔市場主導地位，市場佔有率高達93.6%。定量檢測領域預計將穩定成長，這主要得益於慢性病監測的日益普及。

透過方法

到2026年，化學冷光免疫檢測法將憑藉其高靈敏度和高效率，以48.28%的市佔率佔領先地位。酵素連結免疫吸附試驗（ELISA）因其成本效益，仍是可行的替代方案。

透過實施環境

到2026年，檢查室檢測將佔市場主導地位，市佔率高達97.24%。這主要得益於診斷檢查室數量的成長。然而，即時檢測預期成長速度將更快。

依檢體類型

預計到 2026 年，血液檢體檢測將佔市場佔有率的 91.62%，因為血液檢測仍然是診斷乙型肝炎的標準方法。

最終用戶

由於臨床檢查室進行大量檢測，因此推動了市場發展，但預計醫院和診所也將穩定成長。

區域趨勢

  • 北美：在強大的醫療保健系統和政府資金的支持下，預計到 2025 年將達到 5.6 億美元，到 2026 年將達到 5.9 億美元。
  • 歐洲：在篩檢計畫增加的支持下，預計到 2025 年市場規模將達到 4.5 億美元，到 2026 年將達到 4.7 億美元。
  • 亞太地區：預計到 2025 年將達到 1.7 億美元，到 2026 年將達到 1.9 億美元，由於中國和印度等國家疾病流行率較高，該地區預計將經歷最快的成長。
  • 拉丁美洲、中東和非洲：由於醫療保健服務的改善和宣傳活動的發展，這些地區呈現穩定成長的態勢。

目錄

第1章：引言

第2章摘要整理

第3章 市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第4章：主要考慮因素

  • 2025年主要國家B型肝炎發生率
  • 價格分析－按主要國家/地區分類，2025 年
  • 新產品發布：按主要企業分類
  • 關鍵產業趨勢（併購、合作）
  • 新冠疫情對市場的影響

第5章：2021-2034年全球B肝表面抗原檢測市場分析、洞察與預測

  • 市場分析、洞察與預測：按類型
    • 定性
    • 定量
  • 市場分析、洞察與預測：按方法論分類
    • 層析法免疫檢測
    • 化學冷光免疫檢測
    • 酵素免疫分析法（ELISA）
  • 市場分析、洞察與預測：按設施類型分類
    • 照護端
    • 檢查室基地
  • 市場分析、洞察與預測：按樣本類型
    • 血
    • 電漿
    • 其他
  • 市場分析、洞察與預測：按最終用戶分類
    • 醫院和診所
    • 臨床檢查室
    • 其他
  • 分析、洞察與預測：按地區分類
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章：北美乙肝表面抗原檢測市場分析、洞察與預測（2021-2034年）

  • 國家
    • 美國
    • 加拿大

第7章：歐洲B肝表面抗原檢測市場分析、洞察與預測（2021-2034年）

  • 國家
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 斯堪地那維亞
    • 其他歐洲國家

第8章：亞太地區乙肝表面抗原檢測市場分析、洞察與預測（2021-2034年）

  • 國家
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 台灣
    • 韓國
    • 新加坡
    • 香港
    • 東南亞
    • 其他亞太國家

第9章：拉丁美洲乙肝表面抗原檢測市場分析、洞察與預測（2021-2034年）

  • 國家
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第10章：中東和非洲乙型肝炎表面抗原檢測市場分析、洞察與預測（2021-2034年）

  • 國家
    • 南非
    • GCC
    • 其他中東和非洲國家

第11章 競爭分析

  • 全球市佔率分析（2025 年）
  • 公司簡介
    • CTK Biotech, Inc.
    • Biopanda Reagents Ltd
    • Avecon Healthcare Pvt. Ltd.
    • Abbott
    • Bio-Rad Laboratories, Inc.
    • Siemens Healthcare Private Limited
    • F. Hoffmann-La Roche Ltd
    • Elabscience Bionovation Inc.
Product Code: FBI110984

Growth Factors of HBsAg testing Market

The global HBsAg testing market was valued at USD 1.44 billion in 2025 and is projected to grow to USD 1.53 billion in 2026, reaching USD 2.44 billion by 2034, exhibiting a CAGR of 6.07% during 2026-2034. North America dominated the market with a 38.89% share in 2025, supported by advanced diagnostic infrastructure and strong screening initiatives.

HBsAg (Hepatitis B Surface Antigen) testing plays a critical role in diagnosing hepatitis B infection by detecting viral antigens in the bloodstream. The growing global burden of hepatitis B, along with rising awareness and screening programs, is significantly boosting market demand.

Market Drivers

Rising Burden of Hepatitis B

The increasing prevalence of hepatitis B is a major factor driving demand for HBsAg testing. According to global health estimates, millions of people continue to live with chronic hepatitis B infections, creating a strong need for early diagnosis and monitoring. Increased transmission risks in healthcare settings and developing regions further accelerate testing demand.

Government Initiatives & Screening Programs

Governments and health organizations are actively promoting hepatitis B screening. Guidelines recommending routine testing-especially among pregnant women and adults-are increasing the number of tests conducted annually. Global elimination programs targeting hepatitis B by 2030 are further strengthening market growth.

Market Trends

Growing Adoption of Advanced Diagnostic Technologies

There is a rising demand for advanced testing techniques such as chemiluminescence immunoassays and rapid diagnostic tests. These technologies offer higher sensitivity, faster results, and improved efficiency, making them preferable in both laboratory and point-of-care settings.

Expansion of Point-of-Care Testing

The market is witnessing a shift toward point-of-care (POC) testing, enabling faster diagnosis in remote and low-resource settings. Additionally, digital health integration and home-based testing solutions are gaining traction, improving accessibility and convenience.

Market Restraints

Accuracy Limitations and False Results

HBsAg tests may sometimes produce false positives or false negatives due to sensitivity limitations or environmental conditions. These inaccuracies can affect diagnosis reliability and hinder widespread adoption.

Availability of Alternative Tests

The presence of alternative diagnostic methods such as anti-HBs and IgM anti-HBc tests may reduce reliance on HBsAg testing, thereby restraining market growth.

Market Opportunities

Increasing R&D for Innovative Testing Solutions

Market players and research institutions are investing heavily in developing advanced diagnostic tools, including self-testing kits and rapid assays. These innovations aim to improve early detection and expand testing accessibility globally.

Expansion in Emerging Markets

Developing regions present significant growth opportunities due to rising awareness, improving healthcare infrastructure, and increasing government initiatives for disease control.

Segmentation Analysis

By Type

The qualitative segment dominated the market with a 93.6% share in 2026, driven by its widespread use in initial screening and diagnosis. The quantitative segment is expected to grow steadily due to increasing chronic disease monitoring.

By Technique

The chemiluminescence immunoassay segment led with a 48.28% share in 2026, owing to its high sensitivity and efficiency. ELISA remains a strong alternative due to cost-effectiveness.

By Setting

The laboratory-based segment dominated with a 97.24% share in 2026, supported by the increasing number of diagnostic laboratories. However, point-of-care testing is expected to grow at a faster rate.

By Sample Type

The blood sample segment held 91.62% share in 2026, as blood testing remains the standard for hepatitis B diagnosis.

By End-user

Clinical laboratories led the market due to high testing volumes, while hospitals and clinics are expected to grow steadily.

Regional Insights

  • North America: Valued at USD 0.56 billion in 2025 and USD 0.59 billion in 2026, driven by strong healthcare systems and government funding.
  • Europe: Reached USD 0.45 billion in 2025 and USD 0.47 billion in 2026, supported by increasing screening programs.
  • Asia Pacific: Valued at USD 0.17 billion in 2025 and USD 0.19 billion in 2026, expected to grow fastest due to high disease prevalence in countries like China and India.
  • Latin America & Middle East & Africa: Showing steady growth due to improving healthcare access and awareness initiatives.

Competitive Landscape

Key players such as Siemens Healthineers AG, F. Hoffmann-La Roche Ltd., and Abbott dominate the market. These companies focus on partnerships, acquisitions, and product innovation to strengthen their market position. Emerging players are also investing in rapid diagnostic technologies to expand their presence.

Conclusion

The HBsAg testing market is set for steady growth, increasing from USD 1.44 billion in 2025 to USD 2.44 billion by 2034, driven by the rising global burden of hepatitis B and strong government screening initiatives. Technological advancements, particularly in rapid and point-of-care testing, are reshaping the diagnostic landscape. However, challenges such as test inaccuracies and limited access in low-resource regions persist. Overall, with continuous innovation, expanding healthcare infrastructure, and global disease elimination efforts, the market is expected to witness sustained growth throughout the forecast period.

Segmentation By Type

  • Qualitative
  • Quantitative

By Technique

  • Enzyme-linked immunosorbent Assay
  • Chemiluminescence Immunoassay
  • Chromatographic Immunoassay

By Setting

  • Point of Care
  • Laboratory-based

By Sample Type

  • Blood
  • Plasma
  • Others

By End-user

  • Hospitals & Clinics
  • Clinical Laboratories
  • Others

By Region

  • North America (By Type, Technique, Setting, Sample Type, End-user, and Country)
    • U.S.
    • Canada
  • Europe (By Type, Technique, Setting, Sample Type, End-user, and Country/Sub-region)
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Sweden
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Type, Technique, Setting, Sample Type, End-user, and Country/Sub-region)
    • Japan
    • China
    • Australia
    • India
    • New Zealand
    • Taiwan
    • South Korea
    • Singapore
    • Hong Kong
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Type, Technique, Setting, Sample Type, End-user, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Type, Technique, Setting, Sample Type, End-user, and Country/Sub-region)
    • South Africa
    • GCC
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Incidence of Hepatitis B - by Key Countries, 2025
  • 4.2. Pricing Analysis - By Key Countries, 2025
  • 4.3. New Product Launches - by Key Players
  • 4.4. Key Industry Development (Mergers, Acquisitions, and Partnerships)
  • 4.5. Impact of COVID-19 on the Market

5. Global HBsAg Testing Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Qualitative
    • 5.1.2. Quantitative
  • 5.2. Market Analysis, Insights and Forecast - By Technique
    • 5.2.1. Chromatographic Immunoassay
    • 5.2.2. Chemiluminescence Immunoassay
    • 5.2.3. Enzyme-linked Immunosorbent Assay (ELISA)
  • 5.3. Market Analysis, Insights and Forecast - By Setting
    • 5.3.1. Point of Care
    • 5.3.2. Laboratory-based
  • 5.4. Market Analysis, Insights and Forecast - By Sample Type
    • 5.4.1. Blood
    • 5.4.2. Plasma
    • 5.4.3. Others
  • 5.5. Market Analysis, Insights and Forecast - By End-user
    • 5.5.1. Hospitals & Clinics
    • 5.5.2. Clinical Laboratories
    • 5.5.3. Others
  • 5.6. Market Analysis, Insights and Forecast - Region
    • 5.6.1. North America
    • 5.6.2. Europe
    • 5.6.3. Asia Pacific
    • 5.6.4. Latin America
    • 5.6.5. Middle East & Africa

6. North America HBsAg Testing Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Qualitative
    • 6.1.2. Quantitative
  • 6.2. Market Analysis, Insights and Forecast - By Technique
    • 6.2.1. Chromatographic Immunoassay
    • 6.2.2. Chemiluminescence Immunoassay
    • 6.2.3. Enzyme-linked Immunosorbent Assay (ELISA)
  • 6.3. Market Analysis, Insights and Forecast - By Setting
    • 6.3.1. Point of Care
    • 6.3.2. Laboratory-based
  • 6.4. Market Analysis, Insights and Forecast - By Sample Type
    • 6.4.1. Blood
    • 6.4.2. Plasma
    • 6.4.3. Others
  • 6.5. Market Analysis, Insights and Forecast - By End-user
    • 6.5.1. Hospitals & Clinics
    • 6.5.2. Clinical Laboratories
    • 6.5.3. Others
  • 6.6. Market Analysis, Insights and Forecast - By Country
    • 6.6.1. U.S.
    • 6.6.2. Canada

7. Europe HBsAg Testing Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Qualitative
    • 7.1.2. Quantitative
  • 7.2. Market Analysis, Insights and Forecast - By Technique
    • 7.2.1. Chromatographic Immunoassay
    • 7.2.2. Chemiluminescence Immunoassay
    • 7.2.3. Enzyme-linked Immunosorbent Assay (ELISA)
  • 7.3. Market Analysis, Insights and Forecast - By Setting
    • 7.3.1. Point of Care
    • 7.3.2. Laboratory-based
  • 7.4. Market Analysis, Insights and Forecast - By Sample Type
    • 7.4.1. Blood
    • 7.4.2. Plasma
    • 7.4.3. Others
  • 7.5. Market Analysis, Insights and Forecast - By End-user
    • 7.5.1. Hospitals & Clinics
    • 7.5.2. Clinical Laboratories
    • 7.5.3. Others
  • 7.6. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.6.1. U.K.
    • 7.6.2. Germany
    • 7.6.3. France
    • 7.6.4. Italy
    • 7.6.5. Spain
    • 7.6.6. Sweden
    • 7.6.7. Scandinavia
    • 7.6.8. Rest of Europe

8. Asia Pacific HBsAg Testing Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Qualitative
    • 8.1.2. Quantitative
  • 8.2. Market Analysis, Insights and Forecast - By Technique
    • 8.2.1. Chromatographic Immunoassay
    • 8.2.2. Chemiluminescence Immunoassay
    • 8.2.3. Enzyme-linked Immunosorbent Assay (ELISA)
  • 8.3. Market Analysis, Insights and Forecast - By Setting
    • 8.3.1. Point of Care
    • 8.3.2. Laboratory-based
  • 8.4. Market Analysis, Insights and Forecast - By Sample Type
    • 8.4.1. Blood
    • 8.4.2. Plasma
    • 8.4.3. Others
  • 8.5. Market Analysis, Insights and Forecast - By End-user
    • 8.5.1. Hospitals & Clinics
    • 8.5.2. Clinical Laboratories
    • 8.5.3. Others
  • 8.6. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.6.1. Japan
    • 8.6.2. China
    • 8.6.3. India
    • 8.6.4. Australia
    • 8.6.5. New Zealand
    • 8.6.6. Taiwan
    • 8.6.7. South Korea
    • 8.6.8. Singapore
    • 8.6.9. Hong Kong
    • 8.6.10. Southeast Asia
    • 8.6.11. Rest of Asia Pacific

9. Latin America HBsAg Testing Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Qualitative
    • 9.1.2. Quantitative
  • 9.2. Market Analysis, Insights and Forecast - By Technique
    • 9.2.1. Chromatographic Immunoassay
    • 9.2.2. Chemiluminescence Immunoassay
    • 9.2.3. Enzyme-linked Immunosorbent Assay (ELISA)
  • 9.3. Market Analysis, Insights and Forecast - By Setting
    • 9.3.1. Point of Care
    • 9.3.2. Laboratory-based
  • 9.4. Market Analysis, Insights and Forecast - By Sample Type
    • 9.4.1. Blood
    • 9.4.2. Plasma
    • 9.4.3. Others
  • 9.5. Market Analysis, Insights and Forecast - By End-user
    • 9.5.1. Hospitals & Clinics
    • 9.5.2. Clinical Laboratories
    • 9.5.3. Others
  • 9.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.6.1. Brazil
    • 9.6.2. Mexico
    • 9.6.3. Rest of Latin America

10. Middle East & Africa HBsAg Testing Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Qualitative
    • 10.1.2. Quantitative
  • 10.2. Market Analysis, Insights and Forecast - By Technique
    • 10.2.1. Chromatographic Immunoassay
    • 10.2.2. Chemiluminescence Immunoassay
    • 10.2.3. Enzyme-linked Immunosorbent Assay (ELISA)
  • 10.3. Market Analysis, Insights and Forecast - By Setting
    • 10.3.1. Point of Care
    • 10.3.2. Laboratory-based
  • 10.4. Market Analysis, Insights and Forecast - By Sample Type
    • 10.4.1. Blood
    • 10.4.2. Plasma
    • 10.4.3. Others
  • 10.5. Market Analysis, Insights and Forecast - By End-user
    • 10.5.1. Hospitals & Clinics
    • 10.5.2. Clinical Laboratories
    • 10.5.3. Others
  • 10.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.6.1. South Africa
    • 10.6.2. GCC
    • 10.6.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. CTK Biotech, Inc.
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Biopanda Reagents Ltd
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Avecon Healthcare Pvt. Ltd.
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Abbott
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Bio-Rad Laboratories, Inc.
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Siemens Healthcare Private Limited
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. F. Hoffmann-La Roche Ltd
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Elabscience Bionovation Inc.
      • 11.2.8.1. Overview
      • 11.2.8.2. Products
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)

List of Tables

  • Table 01: Global HBsAg Testing Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 02: Global HBsAg Testing Market Revenue (USD billion) Forecast, By Technique, 2021-2034
  • Table 03: Global HBsAg Testing Market Revenue (USD billion) Forecast, By Setting, 2021-2034
  • Table 04: Global HBsAg Testing Market Revenue (USD billion) Forecast, By Sample Type, 2021-2034
  • Table 05: Global HBsAg Testing Market Revenue (USD billion) Forecast, By End-user, 2021-2034
  • Table 06: Global HBsAg Testing Market Revenue (USD billion) Forecast, By Region, 2021-2034
  • Table 07: North America HBsAg Testing Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 08: North America HBsAg Testing Market Revenue (USD billion) Forecast, By Technique, 2021-2034
  • Table 09: North America HBsAg Testing Market Revenue (USD billion) Forecast, By Setting, 2021-2034
  • Table 10: North America HBsAg Testing Market Revenue (USD billion) Forecast, By Sample Type, 2021-2034
  • Table 11: North America HBsAg Testing Market Revenue (USD billion) Forecast, By End-user, 2021-2034
  • Table 12: North America HBsAg Testing Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 13: Europe HBsAg Testing Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 14: Europe HBsAg Testing Market Revenue (USD billion) Forecast, By Technique, 2021-2034
  • Table 15: Europe HBsAg Testing Market Revenue (USD billion) Forecast, By Setting, 2021-2034
  • Table 16: Europe HBsAg Testing Market Revenue (USD billion) Forecast, By Sample Type, 2021-2034
  • Table 17: Europe HBsAg Testing Market Revenue (USD billion) Forecast, By End-user, 2021-2034
  • Table 18: Europe HBsAg Testing Market Revenue (USD billion) Forecast, By Country/Sub-region, 2021-2034
  • Table 19: Asia Pacific HBsAg Testing Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 20: Asia Pacific HBsAg Testing Market Revenue (USD billion) Forecast, By Technique, 2021-2034
  • Table 21: Asia Pacific HBsAg Testing Market Revenue (USD billion) Forecast, By Setting, 2021-2034
  • Table 22: Asia Pacific HBsAg Testing Market Revenue (USD billion) Forecast, By Sample Type, 2021-2034
  • Table 23: Asia Pacific HBsAg Testing Market Revenue (USD billion) Forecast, By End-user, 2021-2034
  • Table 24: Asia Pacific HBsAg Testing Market Revenue (USD billion) Forecast, By Country/Sub-
  • Table 25: Latin America HBsAg Testing Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 26: Latin America HBsAg Testing Market Revenue (USD billion) Forecast, By Technique, 2021-2034
  • Table 27: Latin America HBsAg Testing Market Revenue (USD billion) Forecast, By Setting, 2021-2034
  • Table 28: Latin America HBsAg Testing Market Revenue (USD billion) Forecast, By Sample Type, 2021-2034
  • Table 29: Latin America HBsAg Testing Market Revenue (USD billion) Forecast, By End-user, 2021-2034
  • Table 30: Latin America HBsAg Testing Market Revenue (USD billion) Forecast, By Country/Sub-region, 2021-2034
  • Table 31: Middle East & Africa HBsAg Testing Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 32: Middle East & Africa HBsAg Testing Market Revenue (USD billion) Forecast, By Technique, 2021-2034
  • Table 33: Middle East & Africa HBsAg Testing Market Revenue (USD billion) Forecast, By Setting, 2021-2034
  • Table 34: Middle East & Africa HBsAg Testing Market Revenue (USD billion) Forecast, By Sample Type, 2021-2034
  • Table 35: Middle East & Africa HBsAg Testing Market Revenue (USD billion) Forecast, By End-user, 2021-2034
  • Table 36: Middle East & Africa HBsAg Testing Market Revenue (USD billion) Forecast, By Country/Sub-region, 2021-2034

List of Figures

  • Figure 01: Global HBsAg Testing Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 02: Global HBsAg Testing Market Value Share (%), By Type, 2025 & 2034
  • Figure 03: Global HBsAg Testing Market Value Share (%), By Technique, 2025 & 2034
  • Figure 04: Global HBsAg Testing Market Value Share (%), By Setting, 2025 & 2034
  • Figure 05: Global HBsAg Testing Market Value Share (%), By Sample Type, 2025 & 2034
  • Figure 06: Global HBsAg Testing Market Value Share (%), By End-user, 2025 & 2034
  • Figure 07: Global HBsAg Testing Market Value Share (%), By Region, 2025 & 2034
  • Figure 08: North America HBsAg Testing Market Value (USD billion), by Type, 2025 & 2034
  • Figure 09: North America HBsAg Testing Market Value Share (%), by Type, 2025
  • Figure 10: North America HBsAg Testing Market Value (USD billion), by Technique, 2025 & 2034
  • Figure 11: North America HBsAg Testing Market Value Share (%), by Technique, 2025
  • Figure 12: North America HBsAg Testing Market Value (USD billion), by Setting, 2025 & 2034
  • Figure 13: North America HBsAg Testing Market Value Share (%), by Setting, 2025
  • Figure 14: North America HBsAg Testing Market Value (USD billion), by Sample Type, 2025 & 2034
  • Figure 15: North America HBsAg Testing Market Value Share (%), by Sample Type, 2025
  • Figure 16: North America HBsAg Testing Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 17: North America HBsAg Testing Market Value Share (%), by End-user, 2025
  • Figure 18: North America HBsAg Testing Market Value (USD billion), by Country, 2025 & 2034
  • Figure 19: North America HBsAg Testing Market Value Share (%), by Country, 2025
  • Figure 20: Europe HBsAg Testing Market Value (USD billion), by Type, 2025 & 2034
  • Figure 21: Europe HBsAg Testing Market Value Share (%), by Type, 2025
  • Figure 22: Europe HBsAg Testing Market Value (USD billion), by Technique, 2025 & 2034
  • Figure 23: Europe HBsAg Testing Market Value Share (%), by Technique, 2025
  • Figure 24: Europe HBsAg Testing Market Value (USD billion), by Setting, 2025 & 2034
  • Figure 25: Europe HBsAg Testing Market Value Share (%), by Setting, 2025
  • Figure 26: Europe HBsAg Testing Market Value (USD billion), by Sample Type, 2025 & 2034
  • Figure 27: Europe HBsAg Testing Market Value Share (%), by Sample Type, 2025
  • Figure 28: Europe HBsAg Testing Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 29: Europe HBsAg Testing Market Value Share (%), by End-user, 2025
  • Figure 30: Europe HBsAg Testing Market Value (USD billion), by Country/Sub-region, 2025 & 2034
  • Figure 31: Europe HBsAg Testing Market Value Share (%), by Country/Sub-region, 2025
  • Figure 32: Asia Pacific HBsAg Testing Market Value (USD billion), by Type, 2025 & 2034
  • Figure 33: Asia Pacific HBsAg Testing Market Value Share (%), by Type, 2025
  • Figure 34: Asia Pacific HBsAg Testing Market Value (USD billion), by Technique, 2025 & 2034
  • Figure 35: Asia Pacific HBsAg Testing Market Value Share (%), by Technique, 2025
  • Figure 36: Asia Pacific HBsAg Testing Market Value (USD billion), by Setting, 2025 & 2034
  • Figure 37: Asia Pacific HBsAg Testing Market Value Share (%), by Setting, 2025
  • Figure 38: Asia Pacific HBsAg Testing Market Value (USD billion), by Sample Type, 2025 & 2034
  • Figure 39: Asia Pacific HBsAg Testing Market Value Share (%), by Sample Type, 2025
  • Figure 40: Asia Pacific HBsAg Testing Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 41: Asia Pacific HBsAg Testing Market Value Share (%), by End-user, 2025
  • Figure 42: Asia Pacific HBsAg Testing Market Value (USD billion), by Country/Sub-region, 2025 & 2034
  • Figure 43: Asia Pacific HBsAg Testing Market Value Share (%), by Country/Sub-region, 2025
  • Figure 44: Latin America HBsAg Testing Market Value (USD billion), by Type, 2025 & 2034
  • Figure 45: Latin America HBsAg Testing Market Value Share (%), by Type, 2025
  • Figure 46: Latin America HBsAg Testing Market Value (USD billion), by Technique, 2025 & 2034
  • Figure 47: Latin America HBsAg Testing Market Value Share (%), by Technique, 2025
  • Figure 48: Latin America HBsAg Testing Market Value (USD billion), by Setting, 2025 & 2034
  • Figure 49: Latin America HBsAg Testing Market Value Share (%), by Setting, 2025
  • Figure 50: Latin America HBsAg Testing Market Value (USD billion), by Sample Type, 2025 & 2034
  • Figure 51: Latin America HBsAg Testing Market Value Share (%), by Sample Type, 2025
  • Figure 52: Latin America HBsAg Testing Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 53: Latin America HBsAg Testing Market Value Share (%), by End-user, 2025
  • Figure 54: Latin America HBsAg Testing Market Value (USD billion), by Country/Sub-region, 2025 & 2034
  • Figure 55: Latin America HBsAg Testing Market Value Share (%), by Country/Sub-region, 2025
  • Figure 56: Middle East & Africa HBsAg Testing Market Value (USD billion), by Type, 2025 & 2034
  • Figure 57: Middle East & Africa HBsAg Testing Market Value Share (%), by Type, 2025
  • Figure 58: Middle East & Africa HBsAg Testing Market Value (USD billion), by Technique, 2025 & 2034
  • Figure 59: Middle East & Africa HBsAg Testing Market Value Share (%), by Technique, 2025
  • Figure 60: Middle East & Africa HBsAg Testing Market Value (USD billion), by Setting, 2025 & 2034
  • Figure 61: Middle East & Africa HBsAg Testing Market Value Share (%), by Setting, 2025
  • Figure 62: Middle East & Africa HBsAg Testing Market Value (USD billion), by Sample Type, 2025 & 2034
  • Figure 63: Middle East & Africa HBsAg Testing Market Value Share (%), by Sample Type, 2025
  • Figure 64: Middle East & Africa HBsAg Testing Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 65: Middle East & Africa HBsAg Testing Market Value Share (%), by End-user, 2025
  • Figure 66: Middle East & Africa HBsAg Testing Market Value (USD billion), by Country/Sub-region, 2025 & 2034
  • Figure 67: Middle East & Africa HBsAg Testing Market Value Share (%), by Country/Sub-region, 2025
  • Figure 68: Global HBsAg Testing Market Share (%), 2025